Device Trial Radar · NCT01675492
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
Last checked: Nov 20, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
126
Actual
Start
Dec 6, 2012
Primary completion
Nov 22, 2016
Study completion Nov 22, 2016
Sponsor
- Lead sponsor
- Abbott Medical OpticsPublic (ABT)
- Sponsor type
- Industry
- First posted
- Aug 30, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To demonstrate that wavefront-guided LASIK with measurements from iDesign is safe and effective in the treatment of mixed astigmatism.
Conditions
- Astigmatism
Interventions
LASIKDevice
Surgeons will perform wavefront-guided LASIK based upon measurements obtained with the iDesign System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Line Loss of More Than Two Lines for Best Spectacle Corrected Visual Acuity (BSCVA)Time frame: 3 Months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.